Authors
Latest:
Future Directions in the Treatment of Opioid-Induced ConstipationA panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.
Latest:
Advancing the State of Precision Medicine In Rheumatoid ArthritisExpert rheumatologists discuss precision medicine in rheumatoid arthritis. In particular, they discuss available data and the value of various tools in guiding treatment selection in routine clinical practice.
Latest:
The Role of Screening, Addressing Cognitive Impairment in Heart Failure ManagementEiran Gorodeski, MD, MPH, Parag Goyal, MD, MSc, and James Fang, MD, discuss the HFSA's recent scientific statement on the prevalence and impact of cognitive impairment on the management of heart failure.
Latest:
Moving Beyond the Joint: The Interplay Between Gout and Kidney DiseaseNehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.
Latest:
Exploring the Cardiovascular Benefits, Potential of FinerenoneIn the final part of this 5-part series, Lala-Trindade discusses the findings of the FINEARTS-HF trial and how it might inform use of finerenone.
Latest:
Beyond Skin Deep: Validating and Transforming SD Patient CareDermatologists end their discussion on seborrheic dermatitis (SD), highlighting key takeaways for patients and clinicians on managing this condition.
Latest:
Role of Advocacy, Patient Voice in Hepatitis BIn this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the role of advocacy and patient voice in HBV management.
Latest:
Anti-VEGF for RVO: The Gold StandardJohn W Kitchens, MD, bookends the discussion by highlighting the landscape of branch vein occlusion (BRVO) treatment options.
Latest:
Addressing Stigma to Improve Outcomes in Alcohol-Related Liver DiseaseThe second segment of a special report stresses the importance of cross-specialty collaboration with hepatology and psychiatry when treating alcohol-related liver disease.
Latest:
Collaboration and Communication Across the Healthcare TeamThe expert panel concludes its discussion with insights on how collaboration and communication across various healthcare specialties improve the care of patients treated for iron deficiency anemia.
Latest:
Using DOACs in People with Chronic Kidney Disease, with Kim Zuber, PA-C, and Jane Davis, DNPKim Zuber, PA-C, and Jane Davis, DNP, offer insight into the use of DOACs in people with atrial fibrillation and chronic kidney disease.
Latest:
Cardiometabolic Medicine: Seeing the Patient as a WholeThe panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.
Latest:
Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment ChangesSilvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, conclude by sharing their approaches to evaluating patient satisfaction and expectations when providing care for ulcerative colitis and Crohn's disease, while also touching upon the importance of discussing the potential need for escalating or switching therapies to better manage the underlying disease processes.
Latest:
Finding a Role for GLP-1 RAs, Incretin Therapies in Heart Failure, with Muthiah Vaduganathan, MD, MPHMuthiah Vaduganathan, MD, MPH, discusses the need for cardiology to embrace a role for GLP-1 receptor agonists and incretin therapies, with a focus on obesity-related HFpEF.
Latest:
AI-Assisted Colonoscopy: New Research and Guidelines for Clinical UseComputer-aided detection during colonoscopies with AI may help increase adenoma detection rates.
Latest:
Practice Pearls for the Management of SCDA panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.
Latest:
Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Madeline King, PharmD, BCIDP, provide insight on vaccine hesitancy among patients and the importance of increasing vaccine uptake to protect against SARS-CoV-2.
Latest:
Unmet Needs, Future Research in Schizophrenia and Muscarinic AgonistsIn part 5 of 5, experts discuss ongoing unmet needs and future research priorities in schizophrenia management.
Latest:
Managing Patients With High-Risk PDR and DMEEhsan Rahimy, MD, outlines strategies for managing cases of high-risk PDR and DME, exploring new therapies and synergistic combinations with anti-VEGF and steroids for longer-lasting responses.
Latest:
Key Takeaways on the Optimal Management of Atopic DermatitisClosing out their discussion on the management of atopic dermatitis, expert panelists share clinical pearls and key takeaways from their discussion.
Latest:
Clinical Pearls for the Management of HSAn expert in dermatological conditions discusses office-based procedures that can benefit patients with HS and shares clinical pearls for the management of the disorder.
Latest:
New Topical Agents for Treatment of Plaque PsoriasisThis publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Latest:
Systemic Lupus Erythematosus Treatment Advances: AnifrolumabThe rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.
Latest:
Final Thoughts on Retinal Disease Treatments and OutcomesExperts wrap up their discussion by highlighting key takeaways on the treatment of retinal diseases with anti-vascular endothelial growth factor (Anti-VEGF) therapies.
